NCT04682067

Brief Summary

The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
16 days until next milestone

Study Start

First participant enrolled

January 8, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2022

Completed
Last Updated

May 26, 2022

Status Verified

May 1, 2022

Enrollment Period

1.2 years

First QC Date

December 18, 2020

Last Update Submit

May 25, 2022

Conditions

Keywords

financial incentivescontingency management

Outcome Measures

Primary Outcomes (2)

  • Number of participants completing 6 study visits

    Feasibility outcome: completion of 6 study visits

    5 weeks

  • Number of participants with >80% completion of daily ecological momentary assessments (EMA) completed

    Feasibility outcome: completion of EMA portion of study

    4 weeks

Secondary Outcomes (1)

  • Number of participants with biochemically verified abstinence at 4 weeks post quit

    5 weeks

Study Arms (2)

Contingency Management

EXPERIMENTAL

Participants in the contingency management (CM) treatment arm will receive the usual care (UC) treatment program offered at the Tobacco Treatment Research Program (TTRP) and will be eligible to earn gift cards at each weekly visit on their quit date up until four weeks post-quit for proof of abstinence. They will earn $20 in gift cards for quitting on the specified quit day (i.e., one week after the orientation visit), and this amount will increase by $5 with each successive weekly abstinent visit (i.e., up to $40 in gift cards at 4 weeks post-quit; up to $150 total).

Behavioral: Contingency ManagementBehavioral: Usual Care smoking cessation

Usual Care

PLACEBO COMPARATOR

Participants in the usual care (UC) group will receive the standard smoking cessation treatment offered at the Health Promotion Research Center's Tobacco Treatment Research Program (TTRP) at the University of Oklahoma. This includes at least 4 treatment sessions of counseling and the opportunity to use nicotine replacement therapy or medications.

Behavioral: Usual Care smoking cessation

Interventions

Escalating financial incentives contingent upon biochemical evidence of abstinence

Contingency Management

Usual care smoking cessation support

Contingency ManagementUsual Care

Eligibility Criteria

Age18 Years - 75 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsThe study has no inclusion/exclusion criteria based on gender
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with type 2 diabetes
  • earn a score \> 4 on REALM indicating \> 6th grade English literacy level
  • willing to quit smoking 7 days from their first visit
  • have an expired CO level \>8 ppm suggestive of current smoking at baseline
  • currently smoking \> 5 cigarettes per day
  • willing and able to attend 6 study visits

You may not qualify if:

  • unable to demonstrate use of or unwilling to use the remote CO monitor and phone app

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma Tobacco Research Center

Oklahoma City, Oklahoma, 73104, United States

Location

MeSH Terms

Conditions

Smoking CessationDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Sydney Martinez, PhD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

January 8, 2021

Primary Completion

April 7, 2022

Study Completion

April 7, 2022

Last Updated

May 26, 2022

Record last verified: 2022-05

Locations